Login to Complete an Application or to Access Judging Panel
About The Prize
AAAS and Science Translational Medicine invite applications for the 2021 AAAS Martin and Rose Wachtel Cancer Research Award. This annual award, funded by an endowment established through a generous bequest from Martin L. Wachtel, honors early-career investigators who have performed outstanding work in the field of cancer research. Entrants must have received their Ph.D. or M.D. within the last 10 years (in 2011 or later).
The deadline for application is 1 February 2021.
Award Winner(s) Receives:
The award winner(s) will be invited to deliver a public lecture on their research and receive a cash award of $25,000*. The award-winning Essay(s) will be published in Science Translational Medicine.
*ALL FEDERAL, STATE AND LOCAL TAXES, AND ANY OTHER COSTS AND EXPENSES, ASSOCIATED WITH THE RECEIPT OR USE OF THE PRIZE ARE THE SOLE RESPONSIBILITY OF THE WINNER.
About AAAS Martin and Rose Wachtel Cancer Research Award
Martin Wachtel was a successful businessman who, in 1939, established Albino Farms, a 15-acre farm in New Jersey devoted exclusively to the raising of albino mice and rats for medical research. A modest man, he once described his venture as a “spoke in the wheel of scientific progress.” In 1945, the farm was assigned wholly to meeting the needs of federal agencies and provided over 100,000 mice that year to test the encephalitis vaccine. In later years, Albino Farms provided animals to private laboratories, colleges and universities, as well as government agencies for use in the study of toxicology, hormones, radiology and nutrition. Married but having no children, Wachtel sought to utilize his accumulated wealth to support and recognize those in the medical community who were having the greatest impact.
Questions / Inquiries:
Send inquiries by email to email@example.com.
About Science Translational Medicine
Science Translational Medicine is the leading journal of high-impact, peer-reviewed research at the intersection of biomedical sciences and clinical applications. Part of the Science family of journals, it is published online weekly and showcases exciting translational research that matters most for human health. Topics include immunology, regenerative medicine, cancer, infectious disease, drug discovery, neurology, genomic medicine, bioengineering and other interdisciplinary areas. Highlights are full-length research papers and topical editorials, reviews and perspectives. Learn more and submit your research today at www.ScienceTranslationalMedicine.org.
The American Association for the Advancement of Science (AAAS) is the world’s largest general scientific society and publisher of the journal Science as well as Science Translational Medicine, Science Signaling, Science Advances, Science Robotics and Science Immunology. AAAS was founded in 1848 and includes some 250 affiliated societies and academies of science, serving 10 million individuals. Science has the largest paid circulation of any peer-reviewed general science journal in the world. The nonprofit AAAS is open to all and fulfills its mission to “advance science and serve society” through initiatives in science policy, international programs, science education, public engagement and more. www.aaas.org